Skip to main content
Log in

Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain

  • Experimental Research
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Increased metabolic activity represented by an increase in both anabolism and catabolism in tumours, including gliomas, is a well known phenomenon and utilised in positron emission tomography imaging of tumours. In this study lysosomal enzyme activities of some glycohydrolases were investigated in glioma tissue from human brain. Tumour tissue (ten cases) and brain tissue surrounding the tumour tissue (seven cases) from patients with a histopathological diagnosis of glioblastoma multiforme or anaplastic astrocytoma were analysed for activity of the lysosomal enzymes galactosylceramidase, glucosylceramidase, β-galactosidase, β-N-acetylglucosaminidase, β-glucuronidase, and acid phosphatase. All of the investigated lysosomal enzymes except galactosylceramidase showed increased activity compared with that in normal brain tissue. Moreover, despite sparsity of tumour cells the specimens taken from surrounding areas showed elevated activities of the same enzymes. The findings indicate an upregulation of the activity not only in tumour but also in normal cells of the surrounding area.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allen N (1972) Acid hydrolytic enzymes in brain tumors. Progr Exp Tumor Res 17: 291–307

    PubMed  CAS  Google Scholar 

  2. Boyer MJ, Tannock IF (1993) Lysosomes, lysosomal enzymes and cancer. Adv Cancer Res 60: 269–291

    Article  PubMed  CAS  Google Scholar 

  3. Chiao YB, Hoyson GM, Peters SP, Lee RE, Diven W, Murphy JW, Glew RH (1978) Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease. Proc Natl Acad Sci USA 75:2448–2552

    Article  PubMed  CAS  Google Scholar 

  4. Dynam W (1986) Promoters for housekeeping genes. TIG: 196–197

  5. Fredman P, von Host H, Collins VP, Granholm L, Svennerholm L (1988) Sialyllactotetraocylceramide, a ganglioside marker for human malignant gliomas. J Neurochem 50(3): 912–919

    Article  PubMed  CAS  Google Scholar 

  6. Fredman P, von Holst H, Collins VP, Dellheden B, Svennerholm L (1993) Expression, of gangliosides GD3 and 3′-isoLM1 in autopsy brains from patients with malignant gliomas. J Neurochem 60: 99–105

    Article  PubMed  CAS  Google Scholar 

  7. Glaser JH, Sly WS (1973) β-glucuronidase deficiency mucopolysaccharoidosis: methods for enzymatic diagnosis. J Lab Clin Med 82: 969–977

    PubMed  CAS  Google Scholar 

  8. von Holst H, Ericson K, Bergström M, Norén G (1989) Stereotactic positron emission tomography imaging for brain tumors. In: Lunsford LD (ed) Modern stereotactic surgery. Martinus Nijhoff, Boston, pp 195–205

    Google Scholar 

  9. von Holst H, Nygren C, Boström K, Collins VP, Fredman P (1997) The presence of foetal ganglioside antigens 3′-isoLM1 and 3′6′-isoLD1 in both gliomas and surrounding areas from human brain. Acta Neurochir (Wien) 139(2): 141–145

    Google Scholar 

  10. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  11. Mosskin M, von Holst H, Bergström M, Collins VP, Ericson L, Johnström P, Norén G (1987) Positron emission tomography with11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol Diagn 28: 6: 673–680

    Article  CAS  Google Scholar 

  12. Mosskin M, von Holst H, Ericson K, Norén G (1986) The blood tumour barrier in intracranial tumours studied with x-ray computed tomography and positron emission tomography using 68-Ga-EDTA. Neurosurgery 28: 259–263

    CAS  Google Scholar 

  13. Månsson J-E, Svennerholm L (1982) The use of galactosylceramides with uniform fatty acids as substrates in the diagnosis and carrier detection of Krabbes disease. Clin Chim Acta 126: 127–133

    Article  PubMed  Google Scholar 

  14. Neufeld EF (1991) Lysosomal storage diseases. Annu Rev Biochem 60: 257–280

    Article  PubMed  CAS  Google Scholar 

  15. Reiner O, Horowitz M (1988) Differential expression of glucocerebrosidase-coding gene. Gene 73: 469–478

    Article  PubMed  CAS  Google Scholar 

  16. Rudling MJ, Angelin B, Peterson CO, Collins VP (1990) Low density lipoprotein receptor activity in human intracranial tumours and its relation to the cholesterol requirements. Cancer Res 50: 483–487

    PubMed  CAS  Google Scholar 

  17. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76–85

    Article  PubMed  CAS  Google Scholar 

  18. Svennerholm L, Håkansson G, Månsson J-E, Vanier MT (1979) The assay of sphingolipid hydrolases in white blood cells with labelled natural substrates. Clin Chim Acta 92: 53–64

    Article  PubMed  CAS  Google Scholar 

  19. Svennerholm L, Månsson J-E, Rosengraen B (1986) Cerebroside-β-glucosidase activity in Gaucher brain. Clin Genet 30: 131–135.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nygren, C., von Holst, H., Månsson, JE. et al. Increased activity of lysosomal glycohydrolases in glioma tissue and surrounding areas from human brain. Acta neurochir 139, 146–150 (1997). https://doi.org/10.1007/BF02747195

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02747195

Keywords

Navigation